Global Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Research Report 2023

Publication ID:

PB510235310

Publication Date:

October 17, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxine contained in the products Borgal, Trivetrin, or Trimidox.
The global Veterinary Active Pharmaceutical Ingredients (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Active Pharmaceutical Ingredients (API) market research.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 146%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary Active Pharmaceutical Ingredients (API) market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Alivira Animal Health Ltd
Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
Procyon Life Sciences
SUANFARMAOfichem Group
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Excel Veterinary HealthcareVetpharma(Insud Pharma)
Menadiona
lndukern Group
LasaSupergenerics Ltd.
Segment by Type
Chemical Based API
Biological API
Highly Potent APl(HPAPI)
Segment by Application
CDMO
CMO
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Veterinary Active Pharmaceutical Ingredients (API) report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, 麻豆原创 Channel and Customer Analysis
Chapter 8: 麻豆原创 Opportunities and Challenges
Chapter 9: 麻豆原创 Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Overview
1.1 Product Overview and Scope of Veterinary Active Pharmaceutical Ingredients (API)
1.2 Veterinary Active Pharmaceutical Ingredients (API) Segment by Type
1.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Chemical Based API
1.2.3 Biological API
1.2.4 Highly Potent APl(HPAPI)
1.3 Veterinary Active Pharmaceutical Ingredients (API) Segment by Application
1.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Value by Application: (2023-2029)
1.3.2 CDMO
1.3.3 CMO
1.4 Global Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue 2018-2029
1.4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales 2018-2029
1.4.3 Global Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Competition by Manufacturers
2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2018-2023)
2.4 Global Veterinary Active Pharmaceutical Ingredients (API) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Product Type & Application
2.7 Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Competitive Situation and Trends
2.7.1 Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Active Pharmaceutical Ingredients (API) Players 麻豆原创 Share by Revenue
2.7.3 Global Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Active Pharmaceutical Ingredients (API) Retrospective 麻豆原创 Scenario by Region
3.1 Global Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2018-2029
3.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2018-2023
3.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2024-2029
3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2018-2029
3.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2018-2023
3.3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2024-2029
3.4 North America Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Facts & Figures by Country
3.4.1 North America Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2029)
3.4.3 North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Facts & Figures by Country
3.5.1 Europe Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2029)
3.5.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2029)
3.6.3 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2029)
3.7.3 Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2018-2029)
4.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2018-2023)
4.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2024-2029)
4.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2018-2029)
4.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2018-2023)
4.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2024-2029)
4.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2018-2029)
5.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023)
5.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2024-2029)
5.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2018-2029)
5.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2018-2023)
5.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2024-2029)
5.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Alivira Animal Health Ltd
6.1.1 Alivira Animal Health Ltd Corporation Information
6.1.2 Alivira Animal Health Ltd Description and Business Overview
6.1.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.1.5 Alivira Animal Health Ltd Recent Developments/Updates
6.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
6.2.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Corporation Information
6.2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Description and Business Overview
6.2.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.2.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments/Updates
6.3 Procyon Life Sciences
6.3.1 Procyon Life Sciences Corporation Information
6.3.2 Procyon Life Sciences Description and Business Overview
6.3.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.3.5 Procyon Life Sciences Recent Developments/Updates
6.4 SUANFARMAOfichem Group
6.4.1 SUANFARMAOfichem Group Corporation Information
6.4.2 SUANFARMAOfichem Group Description and Business Overview
6.4.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.4.5 SUANFARMAOfichem Group Recent Developments/Updates
6.5 NGL Fine-Chem Ltd
6.5.1 NGL Fine-Chem Ltd Corporation Information
6.5.2 NGL Fine-Chem Ltd Description and Business Overview
6.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.5.5 NGL Fine-Chem Ltd Recent Developments/Updates
6.6 Huvepharma
6.6.1 Huvepharma Corporation Information
6.6.2 Huvepharma Description and Business Overview
6.6.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.6.5 Huvepharma Recent Developments/Updates
6.7 Jiangsu Lingyun Pharmaceutical Co. Ltd
6.6.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Corporation Information
6.6.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Description and Business Overview
6.6.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.7.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments/Updates
6.8 Excel Veterinary HealthcareVetpharma(Insud Pharma)
6.8.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Corporation Information
6.8.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Description and Business Overview
6.8.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.8.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments/Updates
6.9 Menadiona
6.9.1 Menadiona Corporation Information
6.9.2 Menadiona Description and Business Overview
6.9.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.9.5 Menadiona Recent Developments/Updates
6.10 lndukern Group
6.10.1 lndukern Group Corporation Information
6.10.2 lndukern Group Description and Business Overview
6.10.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.10.5 lndukern Group Recent Developments/Updates
6.11 LasaSupergenerics Ltd.
6.11.1 LasaSupergenerics Ltd. Corporation Information
6.11.2 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Description and Business Overview
6.11.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.11.5 LasaSupergenerics Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Chain Analysis
7.2 Veterinary Active Pharmaceutical Ingredients (API) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Active Pharmaceutical Ingredients (API) Production Mode & Process
7.4 Veterinary Active Pharmaceutical Ingredients (API) Sales and 麻豆原创ing
7.4.1 Veterinary Active Pharmaceutical Ingredients (API) Sales Channels
7.4.2 Veterinary Active Pharmaceutical Ingredients (API) Distributors
7.5 Veterinary Active Pharmaceutical Ingredients (API) Customers
8 Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Dynamics
8.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Trends
8.2 Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Drivers
8.3 Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Challenges
8.4 Veterinary Active Pharmaceutical Ingredients (API) 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Alivira Animal Health Ltd
Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
Procyon Life Sciences
SUANFARMAOfichem Group
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Excel Veterinary HealthcareVetpharma(Insud Pharma)
Menadiona
lndukern Group
LasaSupergenerics Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.